News | January 23, 2012

Pregnant Women With Life-Threatening Blood Clots Should Receive Aggressive Treatment

January 23, 2012 — Pregnant women who develop dangerous blood clots in the leg often forgo the most effective treatment for fear of harming the baby. Yet treatment to remove the clot is not only safe, it can prevent serious problems, including death, suggests research being presented at the 24th International Symposium on Endovascular Therapy (ISET).

Deep vein thrombosis (DVT) – a blood clot that forms deep in the thigh – is four to six times more common in pregnant women than those who are not pregnant. A smaller blood clot can break off and travel to the lung artery causing a pulmonary embolism. When DVT is not treated early and effectively, the clot can become permanent, causing lifelong pain and blood flow problems. The most effective treatments include the minimally invasive delivery of clot-dissolving drugs directly to the clots to break them up, or surgery.

The study included 11 pregnant women with DVT. Nine were treated with minimally invasive techniques by guiding a tiny tube called a catheter to the site of the clot to deliver a bath of clot-dissolving drugs, and two had surgery to remove the clot. Treatment successfully broke up the clot in all cases. All but one of the pregnancies resulted in a successful birth. One woman in her second trimester miscarried a week after treatment. The woman suffers from antiphospholipid antibody syndrome, which causes the blood to clot abnormally and increases the risk of miscarriage, so the condition likely was the cause of her miscarriage in this case as well, researchers said. Three of the women had successful subsequent pregnancies.

Pregnant women who develop DVT are typically treated less aggressively with blood thinners, which rarely clear the clot.

“Pulmonary embolism is the second most frequent cause of death in pregnant women in North America and the United Kingdom,” said Anthony Comerota, M.D., director of the Jobst Vascular Center at The Toledo Hospital, Ohio. “Physicians should use more effective treatment to prevent these women from having serious life-long problems that can affect their ability to care for their children.”

For more information: www.iset.org


Related Content

News | Cardiovascular Clinical Studies

Aug. 15, 2024 — According to a new study being presented at ACC Asia 2024 in Delhi, India, drinking over 400 mg of ...

Home August 14, 2024
Home
Videos | Cardiovascular Clinical Studies

As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits ...

Home July 30, 2024
Home
News | Cardiovascular Clinical Studies

July 25, 2024 — BioCardia, Inc., a global leader in cellular and cell-derived therapeutics for the treatment of ...

Home July 25, 2024
Home
News | Cardiovascular Clinical Studies

July 18, 2024 — Elucid, a pioneering AI medical technology company providing physicians with imaging analysis software ...

Home July 18, 2024
Home
News | Cardiovascular Clinical Studies

July 10, 2024 — CellProthera, a private company specializing in cell-based therapies for repairing ischemic tissues, and ...

Home July 10, 2024
Home
News | Cardiovascular Clinical Studies

July 9, 2024 — Microbot Medical Inc. announced the completion of the first procedure in a patient utilizing its LIBERTY ...

Home July 09, 2024
Home
News | Cardiovascular Clinical Studies

June 26, 2024 — Semaglutide, a medication initially developed for type 2 diabetes and obesity, significantly improves ...

Home June 26, 2024
Home
News | Cardiovascular Clinical Studies

June 21, 2024 — Lexicon Pharmaceuticals, Inc. announced that the peer-reviewed Journal of the American College of ...

Home June 21, 2024
Home
News | Cardiovascular Clinical Studies

June 20, 2024 — Microbot Medical Inc. announced its agreement with Brigham and Women’s Hospital (BWH), a leading ...

Home June 20, 2024
Home
News | Cardiovascular Clinical Studies

June 20, 2024 — A programming algorithm, being tested by HonorHealth Research Institute for those patients with new or ...

Home June 20, 2024
Home
Subscribe Now